CellSeed Inc. (TYO:7776)
218.00
0.00 (0.00%)
Oct 6, 2026, 3:30 PM JST
CellSeed Market Cap
CellSeed has a market cap or net worth of 8.68 billion as of October 5, 2026. Its market cap has decreased by -41.61% in one year.
Market Cap
8.68B
Enterprise Value
n/a
Revenue
161.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
218.00
ChartMarket Cap Chart
Since March 16, 2010, CellSeed's market cap has increased from 5.26B to 8.68B, an increase of 65.00%. That is a compound annual growth rate of 3.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 8.68B | -3.28% |
| Dec 30, 2025 | 8.98B | -35.09% |
| Dec 30, 2024 | 13.83B | 62.71% |
| Dec 29, 2023 | 8.50B | 107.22% |
| Dec 30, 2022 | 4.10B | 25.55% |
| Dec 30, 2021 | 3.27B | -13.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 10.28B |
| Carna Biosciences | 8.80B |
| K Pharma,Inc. | 8.72B |
| Nano Holdings | 8.62B |
| OncoTherapy Science | 8.57B |
| Kidswell Bio | 8.20B |
| Chiome Bioscience | 8.05B |
| StemCell Institute | 7.47B |